Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 1,793,350	$ 21,547
Prepaid expenses and other assets		9,231
Total current assets	1,793,350	30,778
Property and equipment, net	144,455	6,525
Deposits	16,294
Total assets	1,954,099	37,303
Current liabilities:
Accounts payable	1,520,982	1,790,648
Accrued liabilities	1,708,385	1,094,852
Advances from officer	1,063,865	946,142
Total current liabilities	4,293,232	3,831,642
Total liabilities	4,293,232	3,831,642
Commitments and contingencies
Stockholders’ deficit:
Common stock, $0.0001 par value; 200,000,000 shares authorized; issued and Outstanding 13,523,544 at September 30, 2016 and 13,187,544 at December 31, 2015	1,353	1,319
Common stock issuable	600,000	600,000
Additional paid-in capital	113,654,316	110,136,056
Accumulated deficit	(116,594,862)	(114,531,714)
Total stockholders’ deficit	(2,339,133)	(3,794,339)
Total liabilities and stockholders’ deficit	1,954,099	37,303
Series A Convertible Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock value	0	$ 0
Series A Convertible Preferred Stock [Member] | Angionetics, Inc. [Member]
Stockholders’ deficit:
Preferred stock value	$ 60